Search research articles
Contact Us
Filters
Showing results (21-30 of 111) with videos related to
Page
of 12
Sort By:
Diabetes
|
June 1, 1984
Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes
M Brownlee, H Vlassara, A Cerami
Diabetes
|
December 1, 1980
Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatography
M Brownlee, H Vlassara, A Cerami
Diabetologia
|
September 1, 1982
Assessment of diabetic control by measurement of urinary glycopeptides
H Vlassara, M Brownlee, A Cerami
Diabetes
|
April 1, 1988
Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo
H Vlassara, M Brownlee, A Cerami
Diabetes
|
September 1, 1985
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein
M Brownlee, H Vlassara, A Cerami
Diabetes
|
June 1, 1985
Recognition and uptake of human diabetic peripheral nerve myelin by macrophages
H Vlassara, M Brownlee, A Cerami
Diabetes Care
|
November 1, 1988
Role of advanced glycosylation products in complications of diabetes
A Cerami, H Vlassara, M Brownlee
The Journal of Experimental Medicine
|
October 1, 1986
Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors
H Vlassara, M Brownlee, A Cerami
Diabetes Research and Clinical Practice
|
January 1, 1989
Advanced non-enzymatic tissue glycosylation: significance in late diabetic complications
H Vlassara, M Brownlee, A Cerami
Journal of Cellular Biochemistry
|
January 1, 1986
Role of nonenzymatic glycosylation in atherogenesis
A Cerami, H Vlassara, M Brownlee
Page
of 12
Search research articles
Search
Showing results (21-30 of 111) with videos related to
Sort By:
Page
of 12
Diabetes
|
June 1, 1984
Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes
M Brownlee, H Vlassara, A Cerami
Diabetes
|
December 1, 1980
Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatography
M Brownlee, H Vlassara, A Cerami
Diabetologia
|
September 1, 1982
Assessment of diabetic control by measurement of urinary glycopeptides
H Vlassara, M Brownlee, A Cerami
Diabetes
|
April 1, 1988
Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo
H Vlassara, M Brownlee, A Cerami
Diabetes
|
September 1, 1985
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein
M Brownlee, H Vlassara, A Cerami
Diabetes
|
June 1, 1985
Recognition and uptake of human diabetic peripheral nerve myelin by macrophages
H Vlassara, M Brownlee, A Cerami
Diabetes Care
|
November 1, 1988
Role of advanced glycosylation products in complications of diabetes
A Cerami, H Vlassara, M Brownlee
The Journal of Experimental Medicine
|
October 1, 1986
Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors
H Vlassara, M Brownlee, A Cerami
Diabetes Research and Clinical Practice
|
January 1, 1989
Advanced non-enzymatic tissue glycosylation: significance in late diabetic complications
H Vlassara, M Brownlee, A Cerami
Journal of Cellular Biochemistry
|
January 1, 1986
Role of nonenzymatic glycosylation in atherogenesis
A Cerami, H Vlassara, M Brownlee
Page
of 12